Increasing Inclusion in Biomarker Research

• By: Adam Naples, PhD James McPartland, PhD Yale Child Study Center
• January 1st, 2022
• biomarkers, cognitive impairment, neuroscience, research, science, technology, underrepresentation, Winter 2022 Issue
• 1510    0

A new study being conducted by researchers in the McPartland Lab at the Yale Child Study Center is using technological advancements to bring biomarker discovery research to minimally verbal and cognitively impaired autistic individuals. These individuals have historically been underrepresented in...

Future Directions in Medication Treatments for ASD

• By: Evdokia Anagnostou, MD Bloorview Research Institute at University of Toronto Joel D. Bregman, MD Thompson Center for Autism and Neurodevelopmental Disorders at the University of Missouri Latha V. Soorya, PhD, BCBA Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai
• January 1st, 2012
• glutamate signaling system, molecular genetics, neuroinflammation, neuroscience, oxytocin, research
• 1040    0

There has been enormous growth over the past 10-15 years in research attempting to identify effective medications for children and youth with ASD. A few classes of medications have been shown to be effective for treating specific symptoms associated with autism. There is accumulating data to...